 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: Ro 47-0543
                                 Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: AQ-13 is a 4-aminoquinoline antimalarial compound related to chloroquine [3,7].  The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. | 
 | |||||||||||||||||||||||||||||||||||
| No information available. | 
| Summary of Clinical Use  | 
| AQ-13 has completed a Phase 2 proof of concept study for the treatment of uncomplicated P. falciparum malaria in adults (NCT01614964). The per-protocol analysis of results from this clinical trial indicates that AQ-13 is similarly effective when compared to the approved combination therapy of artemether plus lumefantrine (trade name Coartem®)[6]. | 
| Clinical Trials | |||||
| Clinical Trial ID | Title | Type | Source | Comment | References | 
| NCT01614964 | Studies of a Candidate Aminoquinoline Antimalarial (AQ-13) | Phase 2 Interventional | Tulane University | ||